Viewing nowPregalin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Korea Pharma Co., Ltd.

MFDS item code 201208481 · Approved 2012.11.20 · Insurance code 642802510
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
This medication is used to relieve peripheral and central neuropathic pain in adults. It is also used as an adjunctive treatment for patients with epilepsy, irrespective of the presence of secondary generalized symptoms for partial seizures. Moreover, it is effective in improving the symptoms of fibromyalgia. Overall, it helps manage neurological pain and seizures, thereby improving patient symptoms.
Administer the total daily dose of pregabalin orally in 2 divided doses, with or without food. This medicine is primarily excreted by the kidneys, so the dose should be adjusted in patients with impaired renal function. (See section '5. Patients with renal impairment') 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150mg per day. Based on the response and tolerability of the individual patient, the dose may be increased to 300mg per day after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals up to a maximum of 600mg per day. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150mg per day. Based on the response and tolerability of the individual patient, the dose may be increased to 300mg per day after one week. After an additional week, it may be increased to the target daily dose of 600mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section '4. Discontinuation of treatment') 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150mg per day. Based on the response and tolerability of the individual patient, the dose may be increased to 300mg per day after one week. If necessary, it may subsequently be increased at 7-day intervals up to a maximum of 600mg per day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300mg∼450mg per day. The starting dose is 75mg twice daily (150mg per day), and based on efficacy and tolerability, it may be increased within one week to 150mg twice daily (300mg per day). For patients who do not experience sufficient benefit at a dose of 300mg per day, it may be increased within one week to 225mg twice daily (450mg per day). Although clinical studies have also been conducted at a dose of 600mg per day, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450mg per day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, when discontinuing this medicine, it should be tapered gradually over a period of at least one week. 5. Patients with renal impairment This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an immediate supplemental dose should be administered after every 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) | Total daily dose of pregabalin a | Administration method Starting dose (mg/day) | Maximum dose (mg/day) ≥60 | 150 | 600 | BID or TID ≥30 -<60 | 75 | 300 | BID or TID ≥15 -<30 | 25-50 | 150 | QD or BID <15 | 25 | 75 | QD Supplemental dose after hemodialysis | 25 | 100 | Single dose b TID = Total daily dose divided into 3 doses BID = Total daily dose divided into 2 doses QD = Administer once daily a : The total daily dose (mg/day) should be divided as specified under administration method. b : Supplemental dose refers to a dose administered as a single additional dose. 6. Patients with hepatic impairment No dosage adjustment is necessary in patients with hepatic impairment. 8. Older adults (65 years and older) Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age: Use is not recommended. Adolescent patients aged 12∼17 years: Use is not recommended.
This medication may increase the risk of suicidal thoughts and behaviors, so patients taking it should immediately notify their healthcare provider if they experience mood changes or symptoms of depression. This medication should not be used in patients with hypersensitivity to any component, or in those with certain genetic lactose intolerances. Diabetic patients may need to adjust their blood sugar control medications due to potential weight gain from this drug. If signs of angioedema occur, the medication should be discontinued immediately, and elderly patients should be cautious of dizziness or drowsiness that could lead to injury. Visual disturbances or changes in eyesight may occur, so it is necessary to consult a healthcare provider if abnormal symptoms arise. Discontinuation of this medication should be done gradually under supervision, as withdrawal symptoms such as insomnia, headache, and anxiety may occur if stopped abruptly. Patients with a history of substance abuse should be carefully monitored for potential misuse of this medication. Dosing adjustments may be necessary for patients with impaired kidney function. Patients with severe heart disease should be cautious when using this medication, especially when combined with opioids, due to an increased risk of central nervous system depression. Patients with respiratory diseases or kidney impairment are at higher risk for severe respiratory depression and should have careful dosing adjustments and monitoring. Pregnant women in early pregnancy should avoid taking this medication due to the risk of fetal malformations. Women of childbearing age should use effective contraception. Lactating women should consider discontinuing breastfeeding or stopping the medication, as it can be transmitted through breast milk. This medication can cause dizziness and drowsiness; therefore, patients should confirm their symptoms before driving or operating hazardous machinery. In case of overdose, symptoms may include confusion, drowsiness, and depression. Emergency treatments such as dialysis may be required.
Suicidal thoughts, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, periorbital swelling, upper respiratory tract swelling, dizziness, drowsiness, loss of consciousness, confusion, mental disorders, blurred vision, vision changes, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, suicidal ideation, pain, seizures, hyperhidrosis, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, decreased respiratory function, respiratory diseases, neurological disorders, renal impairment, rhinitis, neutropenia, increased appetite, appetite loss, hypoglycemia, confusion, disorientation, irritability, euphoria, decreased libido, depersonalization, sexual dysesthesia, restlessness, anxiety, mood swings, emotional blunting, emotional elevation, hallucinations, abnormal dreams, increased libido, panic attacks, impulsivity, apathy, dizziness, drowsiness, ataxia, coordination disorders, balance disorders, amnesia, attention disorders, memory impairment, tremors, dysarthria, sensory disturbances, sensory loss, sedation, excessive drowsiness, cognitive impairment, nystagmus, speech disorders, hypertrophy of smooth muscle contractions, reduced reflexes, movement disorders, psychomotor agitation, positional dizziness, hypersensitivity, burning sensation, tremor at rest, syncope, confusion, hypokinesia, olfactory disturbances, loss of taste, writing difficulties, blurred vision, diplopia, loss of indirect vision, visual disturbance, visual field defects, photophobia, dry eyes, eye swelling, decreased vision, eye pain, eye fatigue, increased tear production, eye irritation, mydriasis, during vibration, changes in depth perception, strabismus, visual brightness, vertigo, auditory hypersensitivity, first-degree atrioventricular block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, throat tension, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, bloating, hypersalivation, gastroesophageal reflux disease, oral sensory impairment, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweats, muscle cramps, arthralgia, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasm, neck pain, muscle rigidity, rhabdomyolysis, urinary disorders, urinary incontinence, urinary frequency, renal insufficiency, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, breast discharge, gynecomastia, peripheral edema, edema, gait abnormalities, falls, feeling drunk, dysesthesia, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased serum creatine phosphokinase, increased aspartate aminotransferase, increased blood glucose, reduced platelet count, decreased serum potassium, weight loss, increased serum creatinine, decreased white blood cell count, hypersensitivity, angioedema, allergic reactions, headache, loss of consciousness, mental disorders, keratitis, congestive heart failure, pulmonary edema, nausea, diarrhea, tongue swelling, facial swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis (facial paralysis), affective disorder, drowsiness, confusional state, depression, agitation, restlessness, seizures
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is also important to maintain a temperature between 15 to 30 degrees Celsius while storing the medication to preserve its effectiveness.
A hard capsule with white or light yellow powder, with a white body and cap.
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Korea Pharma Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.